Overview:
Irritable bowel syndrome (IBS) is a gastrointestinal tract disorder that affects the large intestine. IBS disrupts the natural movement of the muscular lining of the intestine to move food along the digestive tract. It is recognized as mild and/or severe, depending on the signs and symptoms, Systems may include diarrhea, constipation, mucus in the stool, bloating and gas, abdominal pain, and cramping. Although there are many ways to treat irritable bowel syndrome, the exact cause of IBS is unknown; it is associated with abnormal gastrointestinal tract movements and increased awareness of bodily functions. IBS can be diagnosed with a stool test, blood test, and endoscopic and/or external imaging procedures. People may experience complications namely infections, ulcerations, and malnutrition and bowel obstructions. IBS treatment helps relieve the patient from the symptoms and improve the quality of life.
Request Here For FREE PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/506
The global irritable bowel syndrome treatment market was valued at US$ 726.1 million in 2016 and is expected to witness a robust CAGR of 12.9% over the forecast period (2017-2025).
Drivers:
Increasing prevalence of irritable bowel syndrome around the world is expected to augment the growth of the global irritable bowel syndrome treatment market over the forecast period. For instance, as reported by the International Foundation for Functional Gastrointestinal Disorders, (IFFGD), in 2016, the prevalence of IBS across the globe was around 10 to 15%. Moreover, between 2.4 and 3.5 million individuals visited a doctor for IBS in the United States alone.
Furthermore, as reported by the Anxiety and Depression Association of America, one in five people in the United States suffer from IBS. IBS shows a wide range of symptoms, therefore, treatment is decided on the predominance of the symptoms. Studies have revealed that IBS is more common in women than men. According to IFFGD, two in three individuals with IBS are female. Thus, there is an increasing demand for safe and effective IBS treatment. Xifaxan (Rifaximin), Linzess (Linclotide), Amitiza (Lubiprostone), and Lotronex (Alosetron) are some of the Food and Drug Administration (FDA) approved drugs used to relieve IBS symptoms.
Regional Insights:
Among regions, North America, Europe, and Asia-pacific are expected to witness significant growth in the global irritable bowel syndrome treatment market due to increasing incidence of IBS, adoption of sedentary lifestyle, increase in levels of stress, and increasing approvals and launches in these regions. For instance, according to an article published in 2017 in the Brandon Gaille, junk food, on average, accounts for around 28.8% of an American’s total caloric intake. Moreover, as reported by the Centers for Disease Control and Prevention (CDC), in 2015, about 1.3% of American adults (3 million adults) were reported to have been diagnosed with IBD.
Furthermore, Market players are focusing on the development, distribution, and marketing of IBS treatment drugs in few countries, such as China and Japan. This in turn is also expected to boost growth of the market in these regions. For instance, in 2015, Sucampo Pharmaceuticals and Herbin Gloria Pharmaceuticals collaborated to commercialize its product in China.
Market Taxonomy:
By Drug Type:
- Lubiprostone
- Linaclotide
- Eluxadoline
- Rifaximin
- Alosetron and others
By Medical Condition:
- IBS-constipation
- IBS-diarrhea
By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/506
Key Players:
Key players active in the global irritable bowel syndrome treatment market are Novartis AG, GlaxoSmithKline, Ardelyx, Inc., Sucampo Pharmaceuticals, Synergy Pharmaceuticals, Abbott Laboratories, Ironwood Pharmaceuticals, Astellas Pharma Inc., and Valeant Pharmaceuticals International, Inc., among others.
Reasons to Purchase this Report
• Current and future of global Irritable Bowel Syndrome Treatment Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓o 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/506
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Drug Type
- Market Snippet By Medical Condition
- Market Snippet By Distribution Channel
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Consumer Trends
- Impact Analysis
- FDA Approval Timeline
- PEST Analysis
- Probiotics & Prebiotics
- Market Dynamics
- Global Irritable Bowel Syndrome Treatment Market, By Drug Type, 2017 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2017 – 2025
- Segment Trends
- Lubiprostone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Linaclotide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Eluxadoline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Rifaximin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Ramosetron Hydrochloride
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Introduction
- Global Irritable Bowel Syndrome Treatment Market, By Medical Condition, 2017 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2017 – 2025
- Segment Trends
- IBS – Constipation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- IBS – Diarrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Introduction
- Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2017 – 2025
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Mn)
- Introduction
- Global Irritable Bowel Syndrome Treatment Market, By Regions, 2017 – 2025 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 – 2025
- North America
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- U.K.
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- China
- Japan
- ASEAN
- Rest of APAC
- Latin America
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- South Africa
- Rest of Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Medical Condition, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2025 (US$ Mn)
- Israel
- Rest of Middle East
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837